LOLIWARE: Funding, Investors & Team (Sep 2026)
The goal of LOLIWARE is to help the world move towards a plastic-free, carbon-free future by developing items that are Meant to Disappear. We are a materials technology company that has won awards, and we are phasing out single-use plastics in favour of biodegradable substitutes produced from seaweed. A broad and international collection of planetary visionaries, scientists, engineers, business leaders, strategists, and technologists are working together to realise this goal of a future free of plastic. Additionally, we've assembled a highly qualified scientific advisory board that includes Dr. Carlos Duarte, a renowned marine biologist who oversees our seaweed supply chain, Dr. Louis Metzger, a former Tierra Biosciences chief scientific officer, and Dr. Garret Miyake, a Sloan research fellow and co-founder of Cypris Materials.
LOLIWARE has raised $9.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LOLIWARE Company Profile and Key Stats
Latest funding round on record: May 2026.
LOLIWARE Funding Rounds
LOLIWARE raised $6.0M in a Seed announced in Feb 2023.
3.3 years later, an undisclosed round of $3.0M was announced in May 2026.
LOLIWARE Founders and Leadership Team
Contact details for the LOLIWARE team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →LOLIWARE Funding Compared to Other Biotechnology Startups
LOLIWARE's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LOLIWARE in Biotechnology and San Jose
Companies Similar to LOLIWARE
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
LOLIWARE Funding FAQs
What does LOLIWARE do?
The goal of LOLIWARE is to help the world move towards a plastic-free, carbon-free future by developing items that are Meant to Disappear. We are a materials technology company that has won awards, and we are phasing out single-use plastics in favour of biodegradable substitutes produced from seaweed. A broad and international collection of planetary visionaries, scientists, engineers, business leaders, strategists, and technologists are working together to realise this goal of a future free of plastic. Additionally, we've assembled a highly qualified scientific advisory board that includes Dr. Carlos Duarte, a renowned marine biologist who oversees our seaweed supply chain, Dr. Louis Metzger, a former Tierra Biosciences chief scientific officer, and Dr. Garret Miyake, a Sloan research fellow and co-founder of Cypris Materials.
How much funding has LOLIWARE raised?
LOLIWARE has raised $9.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in May 2026.
When did LOLIWARE last raise funding?
LOLIWARE's most recent funding round on record is an undisclosed round of $3.0M, announced in May 2026.
Who founded LOLIWARE?
FundedIQ lists Sea F (Founder) at LOLIWARE.
Who is the CEO of LOLIWARE?
Sea Briganti is listed as CEO at LOLIWARE.
Where is LOLIWARE headquartered?
LOLIWARE is based in San Jose, California, United States.
How many employees does LOLIWARE have?
LOLIWARE is in the 11-50 employee band.
How does LOLIWARE's funding compare to other Biotechnology startups?
LOLIWARE's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's LOLIWARE Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LOLIWARE is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.